Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
The latest dividend from NVS was $4.74 per share (ex-dividend 3/11/2026). The dividend yield over the last 12 months is 3,3%. Over the last 12 months there was 1 distribution, totalling $4.74 per share.